A LinkedIn post from STALICLA indicates that CEO and founder Lynn Durham is scheduled to deliver a company presentation at the 26th Bio€quity conference in Prague. The session is set for May 5, 2026, at 12:15 p.m. CET on the Neurology & Age-Related Diseases track at the Prague Congress Centre.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that STALICLA aims to increase visibility among biotech investors and partners active in neurology, neurodevelopmental, and age-related disease fields. For investors, participation in a high-profile Bio€quity track may support future fundraising, partnering, or licensing discussions, and could reinforce the company’s positioning in precision medicine and neurodevelopmental drug development.